Case_NN report_NN :_: Survival_NN after_IN deliberate_JJ strychnine_NN self-poisoning_NN ,_, with_IN toxicokinetic_JJ data_NNS Abstract_NP |_SYM Introduction_NN |_SYM Strychnine_NP poisoning_NN is_VBZ uncommon_JJ ,_, and_CC in_IN most_JJS severe_JJ cases_NNS ,_, the_DT patient_NN dies_VBZ before_IN reaching_VBG hospital_NN ._SENT The_DT management_NN of_IN strychnine_NN poisoning_NN is_VBZ well_RB documented_VBN ,_, although_IN there_EX are_VBP few_JJ data_NNS on_IN the_DT kinetics_NN of_IN elimination_NN of_IN strychnine_NN after_IN overdose_NN ._SENT Case_NN report_NN |_SYM A_DT 42-year-old_JJ man_NN presented_VBD shortly_RB after_IN ingestion_NN of_IN an_DT unknown_JJ quantity_NN of_IN strychnine_NN powder_NN ._SENT After_IN a_DT respiratory_JJ arrest_NN ,_, with_IN intensive_JJ supportive_JJ management_NN requiring_VBG admission_NN to_TO an_DT intensive_JJ care_NN unit_NN ,_, he_PP survived_VBD ._SENT Eight_CD serum_NN samples_NNS were_VBD taken_VBN over_IN the_DT first_JJ 5_CD days_NNS and_CC analysed_VBD subsequently_RB for_IN strychnine_NN concentrations_NNS ._SENT Results_NNS |_SYM The_DT initial_JJ concentration_NN at_IN 1.5_CD hours_NNS after_IN ingestion_NN was_VBD 4.73_CD mg/l_NN ,_, falling_VBG to_TO 0.38_CD mg/l_NN at_IN 74_CD hours_NNS postingestion_NN ._SENT Serum_NP concentrations_NNS followed_VBD a_DT monoexponential_JJ elimination_NN curve_NN with_IN a_DT calculated_JJ elimination_NN half-life_NN of_IN 12_CD hours_NNS ._SENT Discussion_NN and_CC conclusion_NN |_SYM Strychnine_NP poisoning_NN presents_VBZ with_IN classical_JJ features_NNS ,_, and_CC with_IN early_JJ diagnosis_NN and_CC supportive_JJ management_NN ,_, the_DT patient_NN can_MD survive_VB ._SENT The_DT initial_JJ serum_NN concentration_NN of_IN 4.73_CD mg/l_NN is_VBZ the_DT highest_JJS reported_VBN concentration_NN in_IN a_DT patient_NN who_WP has_VBZ survived_VBN ._SENT Previous_JJ reports_NNS of_IN the_DT elimination_NN half-life_NN have_VBP suggested_VBN it_PP is_VBZ between_IN 10_CD and_CC 16_CD hours_NNS ,_, which_WDT conforms_VBZ to_TO the_DT elimination_NN data_NNS in_IN our_PP$ case_NN ._SENT poisoning_NN ,_, respiratory_JJ arrest_NN ,_, strychnine_NN ,_, survival_NN ,_, toxicokinetics_NNS ,_, Strychnine_NP is_VBZ a_DT bitter_JJ ,_, white_JJ ,_, powder_NN alkaloid_NN derived_VBN from_IN the_DT seeds_NNS of_IN the_DT tree_NN Strychnos_NP nux-vomica_NP ._SENT It_PP has_VBZ had_VBN an_DT interesting_JJ past_NN ,_, initially_RB having_VBG been_VBN introduced_VBN in_IN the_DT 16th_JJ century_NN as_IN a_DT rodenticide_NN ,_, and_CC until_IN recently_RB it_PP was_VBD used_VBN as_IN a_DT respiratory_JJ ,_, circulatory_JJ and_CC digestive_JJ stimulant_NN ._SENT It_PP is_VBZ no_RB longer_RBR used_VBN in_IN any_DT pharmaceutical_JJ products_NNS ,_, but_CC is_VBZ still_RB used_VBN as_IN a_DT rodenticide_NN ._SENT Strychnine_NN is_VBZ also_RB found_VBN as_IN an_DT adulterant_NN in_IN street_NN drugs_NNS such_JJ as_IN amphetamines_NNS ,_, heroin_NN and_CC cocaine_NN ._SENT Strychnine_NN poisoning_NN is_VBZ uncommon_JJ ,_, and_CC in_IN most_JJS severe_JJ cases_NNS ,_, the_DT patient_NN dies_VBZ before_IN reaching_VBG hospital_NN ._SENT The_DT management_NN of_IN strychnine_NN poisoning_NN is_VBZ well_RB documented_VBN ,_, but_CC there_EX is_VBZ less_JJR information_NN available_JJ about_IN the_DT elimination_NN kinetics_NN of_IN strychnine_NN ._SENT We_PP report_VBP the_DT toxicokinetics_NN of_IN strychnine_NN in_IN a_DT patient_NN who_WP survived_VBD a_DT deliberate_JJ strychnine_NN ingestion_NN ._SENT A_DT 42-year-old_JJ man_NN with_IN no_DT significant_JJ past_JJ medical_JJ history_NN presented_VBD approximately_RB 1_CD hour_NN after_IN ingestion_NN of_IN a_DT bottle_NN of_IN wine_NN together_RB with_IN some_DT "_`` white_JJ powder_NN "_'' from_IN his_PP$ garden_NN shed_VB (_( this_DT was_VBD later_RBR confirmed_VBN to_TO be_VB strychnine_NN )_) ._SENT He_PP was_VBD able_JJ to_TO walk_VB in_IN to_TO the_DT Emergency_NP Department_NP ,_, but_CC he_PP was_VBD agitated_VBN and_CC ataxic_JJ ,_, in_IN keeping_VBG with_IN his_PP$ ethanol_NN intake_NN ._SENT Within_IN a_DT few_JJ minutes_NNS of_IN his_PP$ arrival_NN ,_, his_PP$ condition_NN rapidly_RB deteriorated_VBN and_CC he_PP developed_VBD a_DT marked_JJ tremor_NN and_CC muscular_JJ spasms_NNS and_CC shortly_RB after_IN this_DT had_VBD a_DT respiratory_JJ and_CC secondary_JJ cardiac_JJ arrest_NN ._SENT At_IN this_DT stage_NN he_PP was_VBD intubated_VBN and_CC ventilated_VBN ,_, and_CC cardiac_JJ output_NN returned_VBN after_IN 5_CD minutes_NNS ._SENT He_PP was_VBD transferred_VBN to_TO the_DT intensive_JJ care_NN unit_NN (_( ICU_NP )_) and_CC the_DT National_NP Poisons_NP Information_NP Service_NP (_( London_NP )_) was_VBD contacted_VBN for_IN further_JJR advice_NN on_IN management_NN ._SENT He_PP continued_VBD to_TO have_VB marked_VBN muscle_NN spasms_NNS and_CC so_RB was_VBD paralysed_VBN with_IN 0.1_CD mg/kg_NN pancuronium_NN given_VBN intravenously_RB ._SENT He_PP was_VBD given_VBN 50_CD g_NN activated_VBN charcoal_NN via_IN a_DT nasogastric_JJ tube_NN ._SENT Postarrest_NP ,_, his_PP$ blood_NN pressure_NN was_VBD 85/40_CD mmHg_NN ,_, heart_NN rate_NN 96_CD beats/min_NN and_CC temperature_NN 38.2C_NN ._SENT Arterial_JJ blood_NN gases_NNS showed_VBD a_DT severe_JJ metabolic_JJ acidosis_NN (_( pH6.51_NP ,_, PaO2_NP 9.5_CD kPa_NN ,_, PaCO2_NP 2.6_CD kPa_NN ,_, HCO3_NP 3.7_CD mmol/l_NN ,_, base_JJ excess_NN [_SYM BE_NP ]_SYM -18_CD )_) and_CC he_PP was_VBD given_VBN 3_CD mmol/kg_NN 8.4_CD %_NN sodium_NN bicarbonate_NN ;_: his_PP$ metabolic_JJ acidosis_NN improved_VBN over_IN the_DT next_JJ 8_CD hours_NNS (_( pH7.26_NP ,_, PaCO2_NP 5.35_CD kPa_NN ,_, PaO2_NP 13.4_CD kPa_NN ,_, HCO3_NP 18_CD mmol/l_NN ,_, BE_NP -9_CD )_) ._SENT He_PP remained_VBD hypotensive_JJ despite_IN fluid_JJ resuscitation_NN and_CC over_IN the_DT first_JJ 24_CD hours_NNS he_PP required_VBD norepinephrine_NN to_TO maintain_VB his_PP$ blood_NN pressure_NN (_( maximum_JJ dose_NN 900_CD g/h_NN )_) ._SENT His_PP$ temperature_NN rose_VBD to_TO 39.9C_JJ on_IN day2_NN but_CC settled_VBN after_IN simple_JJ cooling_NN measures_NNS and_CC rehydration_NN ._SENT His_PP$ creatinine_NN kinase_NN peaked_VBN at_IN 8218_CD IU/l_NN ,_, (_( although_IN there_EX was_VBD no_DT evidence_NN of_IN myoglobinuria_NN )_) and_CC his_PP$ creatinine_NN peaked_VBN at_IN 194_CD mol/l_NN on_IN day_NN 2_CD ._SENT He_PP was_VBD extubated_VBN on_IN day3_NN ,_, initially_RB with_IN some_DT persisting_VBG twitching_VBG and_CC muscular_JJ spasms_NNS ,_, requiring_VBG boluses_NNS of_IN midazolam_NN and_CC diazepam_NN and_CC an_DT alfentanil_NP infusion_NN for_IN analgesia_NN ._SENT By_IN day5_NN he_PP was_VBD asymptomatic_JJ and_CC his_PP$ renal_JJ function_NN had_VBD returned_VBN to_TO normal_JJ ._SENT He_PP was_VBD discharged_VBN from_IN hospital_NN on_IN day10_NN after_IN psychiatric_JJ assessment_NN ._SENT Eight_CD serum_NN samples_NNS were_VBD obtained_VBN over_IN the_DT first_JJ 5_CD days_NNS and_CC subsequently_RB analysed_VBN on_IN a_DT Hewlett-Packard_NP 6890_CD gas_NN chromatograph_NN (_( Stockport_NP ,_, Cheshire_NP ,_, UK_NP )_) equipped_VBD with_IN a_DT nitrogen_NN phosphorous_JJ detector_NN for_IN strychnine_NN concentrations_NNS ._SENT A_DT Restex_NP RTX_NP 1_CD column_NN was_VBD used_VBN with_IN an_DT isothermal_JJ oven_NN temperature_NN of_IN 270C_JJ ._SENT The_DT injector_NN and_CC detector_NN temperatures_NNS were_VBD set_VBN at_IN 250C_JJ and_CC 300C_JJ ,_, respectively_RB ._SENT The_DT strychnine_NN concentrations_NNS are_VBP shown_VBN in_IN Fig._NN ;_: the_DT patient_NN 's_POS initial_JJ concentration_NN at_IN 1.5_CD hours_NNS after_IN ingestion_NN was_VBD 4.73_CD mg/l_NN ,_, falling_VBG to_TO 0.38_CD mg/l_NN and_CC to_TO 0_CD at_IN 74_CD hours_NNS and_CC 100_CD hours_NNS postingestion_NN ,_, respectively_RB ._SENT The_DT data_NNS conformed_VBD to_TO a_DT monoexponential_JJ elimination_NN curve_NN and_CC the_DT calculated_JJ elimination_NN half-life_NN was_VBD 12_CD hours_NNS ._SENT Figure_NP 1_CD |_SYM Serum_NP strychnine_NN concentrations_NNS in_IN a_DT patient_NN with_IN severe_JJ strychnine_NN poisoning_NN ._SENT Serum_NP strychnine_NN concentrations_NNS in_IN a_DT patient_NN with_IN severe_JJ strychnine_NN poisoning_NN ._SENT Strychnine_NN poisoning_NN is_VBZ an_DT uncommon_JJ but_CC potentially_RB fatal_JJ poisoning_NN and_CC most_JJS patients_NNS die_VBP before_IN reaching_VBG hospital_NN ._SENT In_IN the_DT case_NN presented_VBD here_RB ,_, the_DT patient_NN presented_VBD early_RB after_IN ingestion_NN ._SENT He_PP was_VBD initially_RB asymptomatic_JJ but_CC rapidly_RB developed_VBN severe_JJ muscle_NN spasms_NNS leading_VBG to_TO respiratory_JJ arrest_NN ._SENT With_IN meticulous_JJ supportive_JJ care_NN in_IN the_DT ICU_NP he_PP made_VBD a_DT complete_JJ recovery_NN ._SENT The_DT mechanism_NN of_IN action_NN causing_VBG strychnine_NN toxicity_NN is_VBZ well_RB understood_VBN ._SENT This_DT poison_NN is_VBZ a_DT competitive_JJ antagonist_NN of_IN the_DT inhibitory_JJ neurotransmitter_NN glycine_NN at_IN receptors_NNS in_IN the_DT spinal_JJ cord_NN ,_, brain_NN stem_NN and_CC higher_JJR centres_NNS ._SENT It_PP results_VBZ in_IN increased_VBN neuronal_JJ activity_NN and_CC excitability_NN ,_, leading_VBG to_TO increased_VBN muscular_JJ activity_NN ._SENT The_DT classical_JJ features_NNS of_IN strychnine_NN poisoning_NN occur_VBP from_IN 15_CD to_TO 30_CD minutes_NNS after_IN ingestion_NN and_CC include_VB heightened_JJ awareness_NN ,_, muscular_JJ spasms_NNS and_CC twitches_NNS and_CC hypersensitivity_NN to_TO stimuli_NNS ._SENT In_IN large_JJ ingestions_NNS ,_, these_DT can_MD progress_VB to_TO painful_JJ generalised_VBN convulsions_NNS ,_, during_IN and_CC after_IN which_WDT the_DT patient_NN retains_VBZ consciousness_NN ._SENT The_DT cause_NN of_IN death_NN is_VBZ usually_RB respiratory_JJ arrest_NN secondary_JJ to_TO respiratory_JJ muscle_NN spasms_NNS ,_, although_IN prolonged_JJ muscular_JJ spasm_NN can_MD lead_VB to_TO hyperthermia_NN ,_, rhabdomyolysis_NN and_CC associated_JJ renal_JJ failure_NN due_JJ to_TO myoglobinuria_NN ._SENT Severe_JJ metabolic_JJ acidosis_NN can_MD occur_VB due_JJ to_TO increased_VBN lactate_NN levels_NNS following_VBG repeated_JJ muscular_JJ activity_NN ,_, although_IN the_DT lactate_NN is_VBZ rapidly_RB removed_VBN once_IN the_DT muscular_JJ spasms_NNS have_VBP been_VBN controlled_VBN ._SENT Prompt_JJ recognition_NN of_IN poisoning_NN and_CC initiation_NN of_IN treatment_NN are_VBP required_VBN to_TO prevent_VB deterioration_NN and_CC death_NN ._SENT Control_NN of_IN convulsions_NNS and_CC muscular_JJ spasms_NNS requires_VBZ either_DT high_JJ doses_NNS of_IN benzodiazepines_NNS ,_, such_JJ as_IN 1_CD mg/kg_NN diazepam_NN ,_, or_CC ,_, in_IN resistant_JJ cases_NNS ,_, paralysis_NN with_IN neuromuscular_JJ blockers_NNS such_JJ as_IN pancuronium_NN ._SENT In_IN addition_NN ,_, meticulous_JJ supportive_JJ care_NN is_VBZ required_VBN ,_, and_CC careful_JJ monitoring_NN and_CC observation_NN for_IN complications_NNS such_JJ as_IN acute_JJ renal_JJ failure_NN ._SENT Clinical_JJ effects_NNS of_IN strychnine_NN ingestion_NN have_VBP been_VBN seen_VBN at_IN doses_NNS as_IN small_JJ as_IN 2_CD mg_NN in_IN a_DT child_NN and_CC 20_CD mg_NN in_IN an_DT adult_NN ._SENT Survival_NN after_IN ingestion_NN of_IN large_JJ amounts_NNS has_VBZ been_VBN reported_VBN :_: 480_CD mg_NN (_( 24_CD mg/kg_NN )_) in_IN a_DT child_NN and_CC 3750_CD mg_NN in_IN an_DT adult_NN ._SENT Death_NN from_IN strychnine_NN ingestion_NN has_VBZ been_VBN reported_VBN in_IN adults_NNS after_IN doses_NNS as_IN low_JJ as_IN 5_CD to_TO 10_CD mg_NN ._SENT Since_IN severe_JJ ,_, life-threatening_JJ features_NNS have_VBP been_VBN reported_VBN after_IN the_DT ingestion_NN of_IN small_JJ amounts_NNS and_CC patients_NNS can_MD deteriorate_VB rapidly_RB ,_, strychnine_NN ingestion_NN should_MD be_VB regarded_VBN as_IN potentially_RB fatal_JJ and_CC the_DT patient_NN should_MD be_VB admitted_VBN to_TO an_DT ICU_NP for_IN close_JJ observation_NN and_CC appropriate_JJ treatment_NN ._SENT In_IN this_DT case_NN ,_, as_RB with_IN many_JJ other_JJ reported_VBN cases_NNS ,_, both_CC the_DT concentration_NN of_IN strychnine_NN in_IN the_DT preparation_NN ingested_VBD and_CC the_DT amount_NN taken_VBN were_VBD unknown_JJ ._SENT The_DT serum_NN strychnine_NN concentration_NN of_IN 4.73_CD mg/l_NN at_IN 1.5_CD hours_NNS postingestion_NN is_VBZ the_DT highest_JJS reported_VBN concentration_NN that_IN a_DT patient_NN has_VBZ survived_VBN ._SENT In_IN previous_JJ reports_NNS ,_, concentrations_NNS of_IN 2.1_CD mg/l_NN at_IN 3_CD hours_NNS and_CC 3.8_CD mg/l_NN at_IN 0.5_CD hours_NNS caused_VBD death_NN ._SENT The_DT potential_JJ fatal_JJ serum_NN concentration_NN of_IN strychnine_NN is_VBZ not_RB known_VBN and_CC clinical_JJ features_NNS rather_RB than_IN the_DT serum_NN concentration_NN should_MD guide_VB management_NN ._SENT At_IN a_DT postmortem_NN ,_, less_JJR than_IN 4_CD hours_NNS after_IN an_DT intentional_JJ ingestion_NN of_IN strychnine_NN ,_, a_DT serum_NN concentration_NN of_IN just_RB 0.33_CD mg/l_NN was_VBD found_VBN ._SENT A_DT postmortem_JJ study_NN showed_VBD that_IN a_DT strychnine_NN concentration_NN of_IN 3.32_CD mg/l_NN in_IN the_DT blood_NN of_IN the_DT inferior_JJ vena_NN cava_NN was_VBD associated_VBN with_IN concentrations_NNS of_IN 11.4_CD mg/l_NN ,_, 2.42_CD mg/kg_NN ,_, 2.32_CD mg/kg_NN and_CC 98.6_CD mg/kg_NN in_IN bile_NN ,_, brain_NN ,_, skeletal_JJ muscle_NN and_CC liver_NN ,_, respectively_RB ._SENT Of_IN the_DT 50_CD reported_VBN cases_NNS of_IN strychnine_NN poisoning_NN in_IN the_DT past_JJ 36_CD years_NNS ,_, only_RB two_CD nonfatal_NN cases_NNS have_VBP included_VBN data_NNS on_IN serum_NN strychnine_NN concentrations_NNS ._SENT Both_CC of_IN these_DT patients_NNS had_VBD much_RB lower_JJR concentrations_NNS (_( 1.6_CD mg/l_NN at_IN 4_CD hours_NNS after_IN ingestion_NN and_CC 2.17_CD mg/l_NN at_IN 6_CD hours_NNS after_IN ingestion_NN ,_, respectively_RB )_) than_IN that_WDT found_VBD in_IN our_PP$ patient_NN ._SENT The_DT elimination_NN and_CC metabolism_NN of_IN strychnine_NN are_VBP poorly_RB understood_VBN ._SENT Strychnine_NN is_VBZ rapidly_RB absorbed_VBN from_IN the_DT gastrointestinal_JJ tract_NN ,_, with_IN symptoms_NNS occurring_VBG within_IN 10_CD to_TO 20_CD minutes_NNS of_IN ingestion_NN ._SENT It_PP is_VBZ also_RB absorbed_VBN through_IN other_JJ mucous_JJ membranes_NNS ,_, as_RB in_IN poisonings_NNS when_WRB strychnine_NN has_VBZ been_VBN mistaken_VBN for_IN cocaine_NN ._SENT Strychnine_NN has_VBZ been_VBN shown_VBN in_IN animal_JJ studies_NNS to_TO be_VB metabolised_VBN in_IN the_DT liver_NN by_IN cytochrome_NN P-450_NP microsomal_JJ enzymes_NNS ,_, but_CC 1_CD --_: 30_CD %_NN is_VBZ excreted_VBN unchanged_JJ in_IN the_DT urine_NN ._SENT The_DT proportion_NN of_IN strychnine_NN excreted_VBN unchanged_JJ appears_VBZ to_TO be_VB smaller_JJR when_WRB larger_JJR amounts_NNS are_VBP ingested_VBN ._SENT In_IN our_PP$ patient_NN ,_, elimination_NN of_IN strychnine_NN obeyed_VBD first-order_NN kinetics_NNS with_IN a_DT half-life_NN of_IN 12_CD hours_NNS ._SENT Only_RB three_CD other_JJ papers_NNS have_VBP reported_VBN on_IN the_DT elimination_NN kinetics_NN of_IN strychnine_NN ,_, and_CC these_DT provide_VBP conflicting_JJ views_NNS of_IN its_PP$ toxicokinetics_NNS ._SENT Edmunds_NPS and_CC colleagues_NNS were_VBD the_DT first_JJ authors_NNS to_TO describe_VB the_DT elimination_NN of_IN strychnine_NN and_CC theirs_PP is_VBZ the_DT only_RB other_JJ report_NN on_IN the_DT kinetics_NN of_IN strychnine_NN in_IN a_DT patient_NN who_WP survived_VBD ._SENT They_PP reported_VBD a_DT 42-year-old_JJ man_NN who_WP ingested_VBD an_DT unknown_JJ quantity_NN of_IN strychnine_NN and_CC developed_VBD severe_JJ muscle_NN cramps_NNS and_CC convulsions_NNS and_CC had_VBD a_DT respiratory_JJ arrest_NN 35_CD minutes_NNS after_IN ingestion_NN ._SENT In_IN that_DT case_NN ,_, the_DT elimination_NN of_IN strychnine_NN obeyed_VBD first-order_NN kinetics_NNS with_IN a_DT half-life_NN of_IN 10_CD hours_NNS ,_, based_VBN on_IN 19_CD blood_NN samples_NNS collected_VBN over_IN a_DT 53-hour_JJ period_NN ,_, the_DT first_JJ of_IN which_WDT was_VBD taken_VBN at_IN 4_CD hours_NNS after_IN ingestion_NN ._SENT Palatnick_NP et_FW al._FW also_RB reported_VBN first-order_NN kinetics_NNS with_IN a_DT half-life_NN of_IN 16_CD hours_NNS ,_, based_VBN on_IN 18_CD serum_NN concentrations_NNS over_IN a_DT 51-hour_JJ period_NN in_IN a_DT 34-year-old_JJ man_NN after_IN ingestion_NN of_IN 125_CD ml_NN of_IN a_DT 2_CD %_NN strychnine_NN solution_NN ._SENT Heiser_NP et_FW al._FW reported_JJ zero-order_NN kinetics_NNS in_IN a_DT fatal_JJ case_NN in_IN a_DT 51-year-old_JJ man_NN who_WP presented_VBD after_IN ingesting_VBG 4.8_CD g_NN of_IN strychnine_NN ._SENT His_PP$ serum_NN concentrations_NNS were_VBD measured_VBN in_IN only_RB five_CD samples_NNS ,_, ranging_VBG from_IN 3.5_CD mg/l_NN at_IN 0.5_CD hours_NNS after_IN ingestion_NN to_TO <0.1_JJ mg/l_NN at_IN 43_CD hours_NNS after_IN ingestion_NN ._SENT The_DT differences_NNS in_IN the_DT kinetics_NN of_IN strychnine_NN found_VBN in_IN our_PP$ patient_NN from_IN the_DT kinetics_NN in_IN the_DT above_JJ three_CD cases_NNS almost_RB certainly_RB reflect_VB the_DT influence_NN of_IN clinical_JJ parameters_NNS such_JJ as_IN different_JJ periods_NNS of_IN hypotension_NN ,_, metabolic_JJ acidosis_NN and_CC renal_JJ impairment_NN ,_, all_DT of_IN which_WDT would_MD influence_VB hepatic_JJ metabolism_NN and_CC renal_JJ elimination_NN of_IN strychnine_NN ._SENT However_RB ,_, the_DT calculated_JJ half-life_NN of_IN 12_CD hours_NNS in_IN our_PP$ patient_NN is_VBZ comparable_JJ to_TO the_DT half-lives_NNS previously_RB reported_VBD (_( 10_CD hours_NNS and_CC 16_CD hours_NNS )_) ,_, suggesting_VBG that_IN the_DT true_JJ elimination_NN half-life_NN of_IN strychnine_NN lies_VBZ between_IN 10_CD and_CC 16_CD hours_NNS ._SENT We_PP describe_VBP a_DT case_NN of_IN severe_JJ strychnine_NN poisoning_NN with_IN a_DT favourable_JJ outcome_NN in_IN which_WDT the_DT strychnine_NN half-life_NN was_VBD 12_CD hours_NNS ._SENT The_DT patient_NN presented_VBD early_RB ,_, his_PP$ symptoms_NNS were_VBD recognised_VBN and_CC meticulous_JJ supportive_JJ care_NN was_VBD instituted_VBN without_IN delay_NN ._SENT All_DT of_IN these_DT factors_NNS were_VBD probably_RB important_JJ in_IN preventing_VBG what_WP would_MD otherwise_RB have_VB been_VBN a_DT fatal_JJ ingestion_NN of_IN strychnine_NN ._SENT Strychnine_NN overdose_NN is_VBZ rare_JJ but_CC potentially_RB fatal_JJ With_IN prompt_JJ recognition_NN of_IN the_DT characteristic_JJ features_NNS and_CC rapid_JJ supportive_JJ care_NN ,_, survival_NN is_VBZ possible_JJ Ingestion_NN of_IN small_JJ amounts_NNS and/or_CC low_JJ plasma_NN strychnine_NN concentrations_NNS are_VBP associated_VBN with_IN fatality_NN Strychnine_NP has_VBZ a_DT toxicokinetic_JJ half-life_NN in_IN overdose_NN of_IN 12_CD hours_NNS Elimination_NN of_IN strychnine_NN in_IN our_PP$ patient_NN obeyed_VBD firstorder_NN kinetics_NNS ,_, as_RB has_VBZ previously_RB been_VBN reported_VBN None_NN declared_VBD ._SENT BE_VB =_SYM base_JJ excess_NN ;_: ICU_NP =_SYM intensive_JJ care_NN unit_NN ._SENT 